FDA inspection
Reapplix: FDA inspection ending May 11, 2023
FDA inspection 1207681 · No Action Indicated (NAI) · Birkerod
Key facts
| Inspection ID | 1207681 |
|---|---|
| Firm | Reapplix |
| FEI number | 3014326253 |
| Address | Bregnerodvej 133a |
| City | Birkerod |
| Country | Denmark |
| Fiscal year | 2023 |
| Inspection end date | May 11, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data